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Abstract  
Mitochondrial dynamics during nutrient starvation of cancer cells likely exert profound effects on their 
capability for metastatic progression. Here we report that KAP1 (TRIM28), a transcriptional co-adaptor 
protein implicated in metastatic progression in breast cancer, is a pivotal regulator of mitochondrial 
fusion in glucose-starved cancer cells. Diverse metabolic stresses induced Ser473-phosphorylation of 
KAP1 (pS473-KAP1) in a ROS- and p38-dependent manner. Results from live cell imaging and molecular 
studies revealed that during the first 6-8 hr of glucose starvation mitochondria initially underwent 
extensive fusion, but then subsequently fragmented in a pS473-KAP1-dependent manner. Mechanistic 
investigations using phosphorylation-defective mutants revealed that KAP1 Ser473-phosphorylation 
limited mitochondrial hyperfusion in glucose-starved breast cancer cells, as driven by downregulation of 
the mitofusin protein MFN2, leading to reduced oxidative phosphorylation and ROS production. In clinical 
specimens of breast cancer, reduced expression of MFN2 corresponded to poor prognosis in patients. In 
a mouse xenograft model of human breast cancer, there was an association in the core region of tumors 
between MFN2 downregulation and the presence of highly fragmented mitochondria. Collectively, our 
results suggest that KAP1 Ser473 phosphorylation acts through MFN2 reduction to restrict mitochondrial 
hyperfusion, thereby contributing to cancer cell survival under conditions of sustained metabolic stress.
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Introduction 
Cancer cells require more nutrients to support their higher proliferation compared with normal 
cells. For example, increased glucose uptake, also known as Warburg effect, is one of the well-
characterized tumor hallmarks (1). During the course of tumor growth, cancer cells encounter 
various microenvironmental stresses from transient or fluctuating (acute) to diffusion-limited 
(chronic) hypoxia and nutrient starvation. In response to these stress conditions, cells activate a 
number of signaling pathways to survive diverse types of nutrient deprivation (2). One of the 
most prominent adaptive responses is to regulate mitochondrial dynamics (3,4). Mitochondria 
undergo dynamic fusion and fission processes that affect cellular biosynthetic and bioenergetic 
efficiency and emerging evidence suggests that dysregulated mitochondrial dynamics are 
associated with human diseases, including cancers (5). The balance between fragmented 
mitochondria and elongated mitochondria is governed by a family of GTP-dependent dynamin-
related ‘mitochondria-shaping’ proteins (6). While the dynamic-related protein 1 (DRP1) drives 
mitochondrial fission, the mitofusin 1/2 (MFN1/2) and optic atrophy 1 (OPA1) proteins mediate 
fusion of the mitochondrial outer and inner membranes, respectively.  
Based on the distance from the nearest blood vessel, tumors contain well-vascularized and 
poorly vascularized regions, which are thought to utilize mitochondria differently. Aerobic 
oxidative phosphorylation (OXPHOS) is essential for ATP production to support cell growth and 
is also the major intracellular source of reactive oxygen species (ROS). It has been reported that 
glucose deprivation induces metabolic oxidative stress via an increase in the steady-state levels 
of mitochondrial superoxide and hydrogen peroxide (7-10). In addition, it is also well documented 
that the prolonged depletion of various nutrients, such as glucose, glutamine, or arginine, 
induces ROS-triggered cancer cell death (11-14). Considering that mitochondrial fusion 
maximizes ATP generation under nutrient starvation (3,4) and that excessive ROS production is 
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detrimental to the cells (15), regional regulation of mitochondrial function inside the tumors 
becomes essential not only for bioenergetics but also for modulating intracellular redox state. 
Therefore, the ability of tumor cells to dynamically regulate the balance between mitochondrial 
fusion and fission is critical for their adaptation to metabolic stress caused by the temporal 
regional heterogeneity. However, the mechanisms underlying the transition from mitochondrial 
fusion to fission during the course of sustained nutrient depletion are not completely understood.  
KRAB domain-associated protein 1 (KAP1/TRIM28) is a pleiotropic regulator of a diverse 
range of cellular process (16). Notably, overexpressed KAP1 has emerged as an oncogene in 
different types of tumors, including breast cancer (17). Previous work by us and others have 
shown that KAP1 is subjected to phosphorylation at multiple serine (Ser) residues, including 
Ser440, Ser473, Ser501 and Ser824 (16). Among these, although ATM-mediated Ser824 
phosphorylation is associated with DNA damage response (18-22), the kinase responsible for 
and the role of KAP1 Ser473-phosphorylation (pS473-KAP1) in the context of metabolic stress is 
poorly understood. Here, we demonstrated that pS473-KAP1 is transiently activated following 
prolonged starvation by ROS-p38MAPK pathway, and pS473-KAP1 reduces mitochondrial 
hyperfusion, promoting colony formation in response to chronic glucose deprivation. 
Mechanistically, pS473-KAP1-dependent adaptive response is characterized by a reduction of 
MFN2. The accumulation of fragmented mitochondria in the core region, compared to the 
periphery, of xenografted tumors supports the regional heterogeneity of mitochondrial dynamics. 
Lastly, reduced MFN2 expression in breast cancer is associated with poor survival and 
metastasis corroborates the concept that suppression of MFN2-mediated mitochondrial fusion 
may underline the poor prognosis of breast cancer patients. Taken together, our studies suggest 
a paradigm by which ROS-p38MAPK-pS473-KAP1-MFN2 axis prevents mitochondrial 
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hyperfusion during the course of metabolic stress and enables breast cancer cells to survive 
changes in the tumor nutritional microenvironment to promote tumor growth.   
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Materials and Methods 
Cell culture and reagents. MDA-MB-231, MDA-MB-468, MCF7, MEFs cells from ATCC, 
mfn2- and ampk-null MEFs cells from collaborators were obtained during the 6-years of this 
project from 2010 to 2015. Multiple frozen aliquots were established upon the acquisition and all 
experimental cells were passaged for fewer than 20-passages after reviving from liquid N2. Cells 
were cultured in DMEM supplemented with 10% fetal bovine serum. MDA-MB-231/shKPA1, and 
MDA-MB-231/shMFN2 cells were cultured with puromycin (2 µg/ml). MDA-MB-
231/shKAP1/KAP1wt, MDA-MB-231/shKAP1/KAP1S473A, MDA-MB-231/shKAP1/KAP1S473D, 
MDA-MB-231/shKAP1/KAP1S473A/Su9-GFP and MDA-MB-231/shKAP1/KAP1S473D/COX4-
DsRed cells were maintained in the presence of puromycin (2 µg/ml) and G418 (100 µg/ml). 
MDA-MB-231/MFN2 cells were maintained in the presence of G418 (100 µg/ml). All nutrient 
depletion media were prepared with 10% dialyzed fetal bovine serum (Gibco, 26400). The 
glucose depletion medium was DMEM (Gibco, 11966-025) supplemented with sodium pyruvate 
(1 mM). The glutamine depletion medium was DMEM (Gibco, 15-013-CV). The arginine 
depletion medium was DMEM (Gibco, A14431-01) supplemented with L-glutamine (4 mM) and 
L-lysine (0.8 mM). Etomoxir (sc-215009), siRNAs against p38α (sc-29433), p38β (sc-39116) and 
Mfn2 (sc-43928) were from Santa Cruz biotechnology. N-acetyl-L-cysteine (A7250), Mdivi-1 
(M0199), D-glucose (G7021), oligomycin A (75351), Rotenone (R8875) and FCCP (C2920) were 
from Sigma-Aldrich. SB203580 (152121-47-6) was from Biovision.  
Plasmid and cell engineering. shRNA (TRCN0000017998) against the KAP1 3’UTR was 
obtained from The RNAi Consortium. MDA-MB-231/shKAP1 cells were generated using 
lentivirus system as described previously (12). FLAG-S473A-KAP1 and FLAG-S473D-KAP1 
were engineered using FLAG-KAP1 as a template (22), respectively, by the Transformer Site 
Directed Mutagenesis Kit (Clonetech). The MFN2 donor vector (HsCD00039867) was obtained 
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from the DNASU Plasmid Repository. All KAP1 constructs were subcloned into the pDONR201 
donor vector and recombined into lentiviral-gateway-compatible destination vectors with 
tetracycline-responsive promoter using GATEWAY technology (Invitrogen). Lentiviruses were 
generated as described previously (12). All constructs were validated by sequencing analyses. 
Western blot analyses and antibodies. Western blot analysis was conducted as described 
previously(23). Antibodies used were phospho-S473-KAP1 (644602, BioLegend), phospho-
S824-KAP1 (A300-767A, Bethyl), KAP1 (A300-274A, Bethyl), β-actin (MAB1501R), H3K27me3 
(07-449) from Millipore, Tom20 (sc-17764) and GAPDH (sc-25778) from Santa Cruz, phospho-
T172-AMPKα (2535), AMPKα (2532), phospho-T180/Y182-p38 (9216) and p38 (9212) from Cell 
Signaling, MFN1 (GTX116254), MFN2 (GTX102055), OPA1 (GTX48589) and FIS1/TTC11 
(GTX111010) from GeneTex, H3 (39763), H3K9me3 (61013) from Active Motif and Mitoprofile 
OXPHOS Cocktail (MS601) from MitoSciences.  
Cell viability, clonogenic cell survival and apoptosis assay. The acid phosphatase (ACP) 
assay was used to measure cell viability as described previously (12). Briefly, 5000 cells/well in 
the 96-well plate were seeded and incubated with different concentrations of glucose or treated 
with Mdivi-1 (10 µM) for 3-days. Alternatively, clonogenic cell survival was performed 48-hr after 
nutrient deprivation. Cells were trypsinized, combined with suspended cells, and total 100 cells 
were reseeded in 6-well plate for 2-weeks as described previously (7). Apoptosis was analyzed 
by Annexin V/Propidium iodide (PI) staining (BD Pharmingen) as described previously (12).  
Soft-agar colony formation. 5,000 cells were mixed in 0.35% agarose in complete medium 
(top layer) and were plated on 0.7% agarose with complete medium (bottom layer) in 6-well 
plates. Extra medium with different concentration of glucose were added to each wells and the 
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medium were changed every 5-day during the 2-week of cell growth. Colonies were imaged as 
described previously (12). 
Intracellular ROS measurement. ROS measurement was performed using DCFDA (D6883, 
Sigma) staining as described previously (12). Briefly, cells were stained with 1 µM DCFDA for 30-
min and the resulting DCF was analyzed by flow cytometry with a maximum emission ~ 530 nm 
(Gallios,Beckman Coulter or BD Accuri C6). Oxidation-insensitive fluorescent DCF probe was 
used as a control (35848, Sigma).  
RNA-seq and quantitative RT-PCR analyses. Total RNA was isolated from cells using the 
TRIzol reagent (15596-026, Ambion). RNA-seq was conducted by the Integrative Genomics 
Core at City of Hope. RNA-seq data are available in the Gene Expression Omnibus (GEO) 
database (GSE63344). Quantitative RT-PCR for gene expression was performed using Bio-Rad 
system as described previously (12). Mitochondrial D-loop primers, forward: 5’-
GTGGCTTTGGAGTTGCAGTT-3’; reverse: 5’-GAAGCAGATTTGGGTACCAC-3'. Lamin B 
primers, forward: 5’-ATGAAGCGGATGTCTAAGAAAG-3’; reverse: 5’-
CGCCTGGGTCCTGTTTACAC-3’. 
Oxygen consumption rate. The mitochondrial OCR was measured by the Seahorse 
Bioscience XF24 Extracellular Flux Analyzer (Seahorse Bioscience) as described previously (12). 
Briefly, 6 × 104 cells were seeded in XF24 cell culture microplates overnight. On the next day, 
cells were washed and incubated with Mito Assay Medium (Seahorse Bioscience) supplemented 
with glucose (25 mM) and sodium pyruvate (1 mM). The pH value of the Mito Assay Medium was 
adjusted to 7.4. The OCR was assayed by sequential injections of oligomycin (1 µM), FCCP (0.5 
µM) and Rotenone (2.5 µM) according to the manufacturer’s instructions. After the 
measurements, the cells were trypsinized for cell number normalization. 
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ATP assay. ATP production was determined using the ENLITEN® ATP Assay System 
(Promega, FF2000) according to the manufacturer’s instructions. Briefly, cells were harvested in 
cold PBS and then added to 5% trichloroacetic acid (TCA). Subsequently, tris-acetate buffer (pH 
7.75) was used to neutralize the TCA solution to a final concentration of 0.1%. The extracts were 
further diluted 1:100 and an equal volume of rL/L Reagent (Promega, FF2000) was added to 
measure the luminescence using a TD-20e luminometer (Turner). The ATP amount was 
normalized to cell number and the relative ATP level was calculated. 
Immunofluorescence staining and imaging. Tom20 antibody (sc-17764, Santa Cruz) was 
used for immunofluorescence staining to visualize mitochondrial morphology as described 
previously (12). Slides were viewed using a 60X objective on an inverted IX81 microscope 
(Olympus) or LSM 700 Confocal Microscope (Zeiss). Time lapse imaging was obtained by Axio 
Observer Z1 Inverted microscope (Zeiss) with a 20-min interval for 20-h.  Videos were collected 
and processed using ZEN 2012 software. For Electron microscopy studies, serial block-face 
scanning electron microscopy (SBF-SEM) (Zeiss Sigma VP) was used. Cell pellets were 
prepared by the Electron Microscopy Core at City of Hope as described previously (24). Images 
were taken with 5400x magnification. Images were collected and processed using Image-Pro 6.3 
software. 
Xenograft and mouse tumor studies. Animal experiments were approved by the 
Institutional Animal Care and Use Committee at City of Hope. 5x106 MDA-MB-231/COX4-DsRed 
cells were used for subcutaneous injection into the flank of 6-week-old NOD.Cg-
PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice. KRAS-driven salivary gland tumors were generated as 
described previously (25). The primary tumor cells were isolated and engineered with COX4-
DsRed to visualize mitochondria. 3x106 cells were injected subcutaneously into the flank of 
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NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice. Mice were euthanized on day-28 to harvest tumors. 
Formalin-fixed, paraffin-embedded (FFPE) sections were subjected to immunohistochemistry 
(IHC) staining with MFN2 antibody (WH0009927M3, Sigma) by the pathology core at City of 
Hope. Tumors were dissected into core and peripheral regions and subjected to Western blotting 
analysis as described previously (26). Tumors for visualizing COX4-DsRed fluorescence were 
fixed in paraformaldehyde (4%) at 4°C overnight, and then subjected to 15% and 30% sucrose 
infiltration and O.C.T embedding. Sections were sliced at 8 µm on the cryostat (CM3050S, Leica).  
Patient materials and Immunohistochemistry. The institutional review board of Chi-Mei 
Medical Center approved the procurement of formalin-fixed tissue and acquisition of clinical 
information for this study (IRB10210004). IHC staining was performed with MFN2 antibody 
(WH0009927M3, Sigma) as previously described (27) to assess MFN2 expression on 202 
consecutively treated primary breast carcinomas underwent modified radical mastectomy 
without adjuvant chemotherapy between 1997 and 2002. Pathological staging was determined 
based on the 7th edition of American Joint Committee on Cancer (AJCC) system. Immuno-
expression of MFN2 was determined by pathologists (C.F.L and T.Z.C) using H-score, defined 
as H-score = ΣPi (i + 1), where i is the intensity of the stained tumor cells (0 to 3+), and Pi is 
the percentage of stained tumor cells for each intensity. Tumors with H-scores no less than the 
median of all scored cases were classified as high MFN2 expression (Table 1), as described 
previously (28). 
Bioinformatics. The Cancer Genome Atlas (TCGA) dataset, the Netherlands Cancer 
Institute (NKI) dataset and Prognoscan database (http://www.prognoscan.org/) were used for 
data mining of mitochondrial complex genes and KAP1 as well as the clinical relevance (29-32). 
Histograms were generated by software R or GraphPad Prism 6. Heatmap was generated by 
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GENE-E software.   
Statistical Analysis. Data with error bar were presented as mean±SD. Statistical 
significance was determined using the two-tailed Student’s t-test. Chi-square test was used to 
evaluate the correlations between MFN2 expression and various clinicopathological features. 
Survival analyses were performed for disease-specific and distal metastasis-free survivals. 
Survival curves were plotted using the Kaplan-Meier method.  
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Results  
KAP1 mRNA level is elevated in breast tumors and diverse nutrient stresses induce a 
delayed ROS-p38MAPK-dependent KAP1 phosphorylation at Ser473 in breast cancer cells. 
Comparative expression analyses, based on breast cancer datasets from Netherlands Cancer 
Institute (NKI) (31,32), revealed that each distinct breast tumor subgroup showed a unique 
signature of glycolysis and OXPOS gene expression (Figure 1A). Notably, almost all breast 
tumors, irrespective their ER/PR/HER2 status, compared with normal-like samples, exhibited up-
regulation of messages encoding proteins involved in both glycolysis and OXPHOS as well as 
KAP1 (Figure 1A). We further noticed that the expression of selected mitochondrial OXPHOS 
genes was positively associated with KAP1 level (Supplementary Figure S1). Consistent with the 
study by Addison et al., showing that higher KAP1 is associated with poor prognosis in breast 
cancer patients (17), an elevated KAP1 expression in breast tumors was correlated with high 
grades and poor prognosis (Supplementary Figure S2). We next found that glucose depletion 
induced a delayed (at approximately 6-h) and transient (in some cases) KAP1 phosphorylation at 
Ser473 (pS473-KAP1), but not Ser824 (pS824-KAP1) in triple negative breast cancer MDA-MB-
231 and MDA-MB-468 cells (Figure 1B) as well as ER-positive breast cancer MCF7 cells (Figure 
1C, left panel). Moreover, glutamine starvation (Figure 1C, right panel), arginine deprivation 
(Figure 1D, upper panel) and blockage of fatty acid β-oxidation by etomoxir (a CPT-1 inhibitor; 
Figure 1D, lower panel) all increased pS473-KAP1. Together, we proposed that pS473-KAP1 
represents a common response to diverse nutrient starvation in breast cancer cells.  
To identify the pathway for pS473-KAP1 induction, we first found that the AMPK inhibitor, 
compound C did not alter the glutamine starvation-induced pS473-KAP1 (Supplementary Figure 
S3A, upper panel). In parallel, pS473-KAP1 persisted in glutamine-deprived AMPKα1/AMPKα2 
double knockout mouse embryonic fibroblasts (MEFs) (Supplementary Figure S3A, lower panel). 
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Similarly, we used the ATM inhibitor, Ku55933, and knockdown of CHK2 and PKCδ by small 
interfering (si) RNA to exclude the involvement of ATM-CHK2 (33) and PKCδ (34) pathways in 
inducing pS473-KAP1 under starvation (Supplementary Figures S3B, C).  
Based on previous observations that metabolic stress induces ROS production in cells 
(7,12,13), we postulated that ROS induction activates KAP1 Ser473-phosphorylation during 
nutrient deprivations. Indeed, depletion of either glucose or glutamine led to a surge of oxidation 
of DCFDA to DCF (Supplementary Figure S3D, left panel), but not the oxidative-insensitive DCF 
analog (Supplementary Figure S3D, right panel), and N-acetylcysteine (NAC), a ROS scavenger, 
impaired starvation-induced pS473-KAP1 (Supplementary Figure S3E). Next, we found that both 
stress kinase p38MAPK inhibitor, SB203580, and siRNA against p38α/β attenuated starvation-
induced pS473-KAP1 (Figure 1E, Supplementary Figures S3F, G). As expected, SB203580 
reduced H2O2-induced pS473-KAP1, but not pS824-KAP1 (Supplementary Figure S3H). Lastly, 
previous studies have shown that NAC prevents glucose depletion-induced cell death in MCF7 
cells (7). Furthermore, NAC rescued MDA-MB-231 cells from glucose depletion-induced cell 
death (Supplementary Figures S3I, J). Overall, our results were consistent with report by Spitz et 
al. that H2O2 produced inside cells is mediating the effects (7). 
KAP1 Ser473-phosphorylation attenuates mitochondrial OXPHOS. We next explored 
whether pS473-KAP1 regulates ROS generation in the context of glucose deprivation. To 
achieve this goal, wild-type (wt)-KAP1, phosphorylation-defective S473A-KAP1 and 
phosphorylation-mimetic S473D-KAP1 were re-expressed in KAP1-knockdown MDA-MB-231 
(MDA-MB-231/shKAP1) cells, respectively (Figure 2A, lower panel). Considering that 
mitochondrial OXPHOS is the major intracellular ROS source (35), oxygen consumption rate 
(OCR), reflecting the OXPHOS flux, in different KAP1-expressing cells was analyzed. As shown 
in Figure 2A, reconstitution of wt- and S473A-KAP1 increased both basal and FCCP-induced 
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maximal respiration to a higher level than S473D-KAP1 did (upper panel) without significant 
alteration on overall ATP production among these cells (Supplementary Figure S4A, left panel). 
One possibility that reduced mitochondrial number would account for the reduced OCR in 
S473D-KAP1-expressing cells was ruled out (Supplementary Figure S4A, right panel). 
Given that immediate response to nutrient starvation is mitochondrial fusion to protect 
mitochondria from mitophagy and maximizing OXPHOS for energy generation (3,4), we explored 
whether pS473-KAP1 counteracts mitochondrial fusion upon nutrient deprivation. First, glucose-
depletion (6-h) led to mitochondrial elongation, similar to the effect of treatment with Mdivi-1, a 
mitochondrial fission inhibitor (Figure 2B). Time-lapse imaging using MDA-MB-231 cells 
expressing mitochondria-targeted COX4-DsRed further validated this observation (Movie 1 and 
2). As shown in Supplementary Figure S4B, mitochondrial fission started between 8- and 9-h 
post starvations, following mitochondrial fusion. Live cell imaging performed on glucose-starved, 
co-cultured S473A-KAP1/Su9-GFP- and S473D-KAP1/COX4-DsRed-repleted cells revealed that 
less elongated mitochondria were observed in the S473D-KAP1-expressing cells than in the 
S473A-KAP1-expressing counterparts during the course of starvation (Movies 3 and 4). 
Quantitative analyses based on images at 0- and 8-h post glucose starvation (Supplementary 
Figure S5A) validated that the expression of S473D-KAP1 alone shifted mitochondrial 
equilibrium towards fragmented mitochondria and that the replacement of S473A-KAP1 favored 
elongated mitochondria in glucose-starved MDA-MB-231/shKAP1 cells (Figure 2C). Scanning 
electron microscopy (SEM) analyses further confirmed that S473A-KAP1 cells harbored more 
elongated mitochondria with an increase in total mitochondrial surface area (Supplementary 
Figures S5B, C). 
To assess whether unbalanced mitochondrial fusion sensitizes cells toward glucose 
depletion-induced cell death, we assessed cell viability of glucose-starved MDA-MB-231 cells 
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with (or not) Mdivi-1. Figure 2D showed that both glucose deprivation and Mdivi-1 pre-treatment 
increased mitochondrial maximal respiration. Moreover, Mdivi-1 pre-treatment further increased 
ROS signal (Figure 2E) and sensitized cells to glucose starvation-induced cell death 
(Supplementary Figure S5D). Likewise, expression of S473A-KAP1, but not wt- and S473D-
KAP1, significantly decreased the viability of glucose-starved cells (Figure 2F). Together, these 
results supported a positive correlation between mitochondrial hyperfusion and elevated OCR. 
Notably, elevated maximal respiration could account for increased ROS generation.  
pS473-KAP1 down-regulates MFN2 to limit mitochondrial fusion. To understand how 
pS473-KAP1 regulates mitochondrial dynamics, we compared the expression of several 
mitochondrial proteins during the course of glucose starvation. First, neither the steady-state 
levels of respective inner mitochondrial membrane complex proteins including NDUFB8 
(complex I), SDHB (complex II), UQCRCII (complex III), COXII (complex IV) and ATP5A 
(complex V), nor the outer mitochondrial membrane protein TOM20, changed during 24-h course 
of glucose deprivation (Figure 3A). In contrast, a time-dependent decrease in MFN2, a 
mitochondrial fusion protein, was noted (Figure 3A). Likewise, arginine depletion decreased 
MFN2 abundance (Figure 3B). However, MFN2 abundance did not decrease in the glucose-
deprived (8-h) S473A-KAP1-expressing cells (Figure 3C, lane 7 versus lane 3), suggesting that 
pS473-KAP1 down-regulates MFN2. To ascertain the role of MFN2 in regulating OXPHOS, 
MFN2 was knocked down in wt-, S473A- and S473D-KAP1-expressing cells. Clearly, knockdown 
of MFN2 markedly decreased the basal OCR in all cells and the reduced OCR in wt- and S473A-
KAP1-expressing cells was comparable with the basal level of S473D-KAP1-expressing cells 
(Figure 3D). We also observed higher basal ROS in the S473A-KAP1 expressing cells in the 
presence or absence of glucose (Figure 3E). Lastly, the correlation between MFN2 and ROS 
level was established using wild type and mfn2 knockout MEFs (Figure 3F). We next addressed 
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whether different MFN2 level affects nutrient sensitivity in MDA-MB-231 cells. As shown in 
Figure 3G, MFN2 over-expression and knockdown have opposite effect on nutrient sensitivity. 
Together with the observations on the mitochondrial hyperfusion upon arginine starvation in 
MDA-MB-231 cells (Supplementary Figures S5E, F), we proposed that mitochondrial hyperfusion 
aggravated the response to nutrient deprivation. Analyses of the RNA-seq data further 
uncovered additional roles for S473D-KAP1 in elevating the expression of mitochondrial complex 
genes (Figure 3H).  
Association of MFN2 expression and mitochondrial network in vivo. To validate the 
alteration in MFN2 in response to starvation in vivo, xenografted MDA-MB-231/COX4-DsRed 
tumors were analyzed. As expected, the tumor core region, generally considered as areas 
undergoing metabolic stress, showed reduced MFN2 (Figures 4A - B) and with more 
fragmented mitochondria (Figure 4C, upper panel), supporting the notion that reduced MFN2 in 
the core region contributes to the accumulation of fragmented mitochondria via suppressed 
mitochondrial fusion. Next, we used a KRAS-driven mouse salivary gland tumor model 
developed in our laboratory recently (25) to independently validate a higher degree of 
mitochondrial fragmentation in the core region of tumors (Figure 4C, lower panel). Elevated 
H3K9me3 and H3K27me3 marks in the core region of xenografts (Figure 4B), indirectly 
reflecting reduced lysine demethylases (KDMs) activity due to a decrease in their cofactor, α-
ketoglutarate level, attested to the regional metabolic stress inside tumors. Lastly, we sought to 
explore the biological consequence of metabolic stress-induced pS473-KAP1. Figure 4D 
revealed that S473A-KAP1-expressing cells were more sensitive to glucose reduction using an 
anchorage-independent cell growth assay.  
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To assess the pathological relevance of MFN2 level in breast cancer, we found that the 
loss-of-MFN2 expression was associated with adverse clinicopathological features and worse 
patient outcome (Table 1). Notably, MFN2 low expression was significantly associated with 
increments of primary tumor status (p=0.001), nodal metastasis (p=0.033), and stage (p=0.002) 
(Figure 5A). Multivariate analysis showed that loss-of-MFN2 expression, along with higher 
stage, remained to be prognostically significant for disease-specific (p=0.0024) and 
metastasis-free (p<0.0001) survival (Figure 5B). Consistently, the TCGA breast cancer dataset 
showed that MFN2 message was lower in breast tumors compared to normal tissues (Figures 
5C). Data mining on PrognoScan database (http://www.prognoscan.org/) (29) showed that 
reduced MFN2 message was correlated with poor survivals (Figures 5D - G). Altogether, our 
results highlighted the importance of p38/pS473-KAP1/MFN2 pathway in promoting tumor cells’ 
survival under metabolic stress. 
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Discussion 
Cancer cells are usually in a state of chronic oxidative stress and use higher glucose and 
hydroperoxide metabolism for compensation. Therefore, targeting glycolysis and antioxidant 
pathways could be therapeutic strategies for cancer (9,36,37). On the other hand, mitochondrial 
O2 metabolism is critical for the further induction of oxidative stress in cancer upon nutrient 
starvation such as glucose depletion (8,37). Our current findings extend the repertoire of critical 
cellular processes initiated by nutrient starvation, including the induction of pS473-KAP1 through 
ROS-/p38MAPK-dependent pathway and the subsequent down-regulation of MFN2, to reduce 
mitochondrial hyperfusion and OXPHOS in order to ameliorate metabolic oxidative stress. 
Although our pharmacological and genetic approaches suggested the involvement of p38 in this 
process, the specific role of different p38 isoforms in the context of distinct metabolic stress 
remained obscure, and as such, whether other kinases also mediate oxidative stress-induced 
pS473-KAP1 signaling needs further study in the future. Presumably, metabolic stress-triggered 
pS473-KAP1 is a general phenomenon present in both normal and tumor cells. However, since 
proliferating tumor cells usually exhibit higher oxidative stress and metabolic demands, this 
signaling pathway could be more prominent in cancer and depend on cells’ nutrient dependency. 
For example, the fact that MCF7 cells are more glutamine-independent (38) could partially 
explain why glutamine deprivation-induced pS473-KAP1 was less robust in MCF7 cells (Figure 
1C). It is likely that primary mammary epithelial cells are relatively resistant to glucose depletion 
(36). As shown in Figure 6, we propose that pS473-KAP1-mediated MFN2 down-regulation is 
crucial for overcoming nutrient stress during tumor growth.  
Upon prolonged metabolic stress, we noted a marked down-regulation of MFN2 that limits 
the initial hyperfusion response. Although MFN1, another mitofusin, is present, it apparently is 
unable to compensate for the loss of MFN2. This behavior is consistent with previous 
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observations that disruption of either mitofusin gene leads to severe mitochondrial fragmentation 
(39). Clinically, we found lower MFN2 expression correlated with more malignant breast tumors, 
which is consistent with earlier reports proposing MFN2 as a tumor suppressor (40-42). The 
mechanisms underlying the control of mitochondrial dynamics in cancer cells received more 
attention recently. For example, Drp1-mediated mitochondrial fission is linked to tumor 
transformation (43,44). Moreover, more mitochondrial fission is observed in lung cancer 
compared with normal lung cells, and inhibition of mitochondrial fission induces cancer cell death 
(45). Fragmented mitochondria have been shown to promote breast cancer metastasis (46). 
These observations and our results together put mitochondrial dynamics control squarely in the 
driver’s seat of tumor progression and support the notion that MFN2 down-regulation represents 
an additional layer mechanism of preventing mitochondrial hyperfusion process during 
tumorigenesis.  
It has been reported that OCR was elevated under low glucose (0.75 mM) (47) and that 
shifting carbon source from glucose to galactose or acetoacetate induced OCR and subsequent 
mitochondrial elongation (48), attesting to our observations that short-term (< 6-h) starvation of 
glucose increased OCR. Although up-regulation of mitochondrial OXPHOS is beneficial as a 
short-term response to acute nutrient starvation, the increased ROS production from elongated 
mitochondria would in turn cause cell death during prolonged starvation. Collectively, our data 
provide a new mechanistic insight into how activation of the KAP1-/MFN2-dependent arm copes 
with metabolic oxidative stress. Given that most cancer cells displayed elevated ROS (49), drugs 
targeting this regulatory circuit could have a positive therapeutic impact by sensitizing cancer 
cells to oxidative stress-based therapeutic strategies.  
To our knowledge, this is the first study demonstrating that KAP1 can be post-translationally 
modified upon metabolic stress. Ideally, we would like to observe a gradient of pS473-KAP1 
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signals, opposite to the MFN2 levels in solid tumors. However, due to the lack of the availability 
of IHC-quality pS473-KAP1 antibody, our repeated efforts failed to detect any pS473-KAP1 
signal using FFPE specimens of either primary patient samples or xenografted tumors. Moreover, 
whether other post-translational modifications of KAP1 also occur under nutrient deprivation to 
regulate metabolic stress response deserves more attention. In the current study, we 
demonstrated that pS473-KAP1 is associated with MFN2 down-regulation upon metabolic stress. 
Although the detailed molecular mechanism is unclear, it is possible that KAP1 directly or 
indirectly regulates MFN2 abundance. Based on our unpublished observations, several 
microRNAs are up-regulated in S473D-KAP1-re-expressing cells. Among these, potential 
starvation-induced and MFN2-targeting microRNA is identified and under investigation.  
In conclusion, we show that ROS-/p38MAPK-induced pS473-KAP1, following the initial 
induction of mitochondrial fusion, prevents mitochondrial hyperfusion by down-regulating MFN2, 
thus promoting the survival of metabolically stressed tumor cells. Our findings not only identify a 
marker(s) potentially useful for breast cancer stratification but also a mechanistic link for tumor 
cells to adapt to metabolic stresses during tumor progression and cancer therapy.  
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Table 1. Correlation between MFN2 expression and various clinicopathological factors. 
Parameters Category No. of case MFN2 Expression  p-valuve 
High Exp. Low Exp. 
Age (years) 
<60 years 141 73 68 0.444 
 ≧60 years 61 28 33  
Primary tumor (T) 
T1 82 53 29 
0.001* 
 T2 96 35 61  
 T3-4 24 13 11  
Nodal status (N) 
N0 117 66 51 
0.033* 
 N1-N2 85 35 50  
Stage 
I 63 43 20 
0.002* 
 II 115 48 67  
 III 24 10 14  
Histological grade 
Grade I 18 13 5 
0.022* 
 Grade II 141 73 68  
 Grade III 43 15 28  
*: Statistically significant 
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Figure legends  
Figure 1. Diverse metabolic stresses induce KAP1 Ser473-phosphorylation in breast 
cancer cells. (A) Overexpression of metabolic genes and KAP1 in breast cancers. Genes were 
selected from 103 NKI samples based on Kyoto Encyclopedia of Genes and Genomes (KEGG) 
database to generate heatmap. (B) Glucose depletion induces dose- and time-dependent KAP1 
Ser473-phosphorylation in TNBC cells. MDA-MB-231 cells were incubated with the indicated 
concentrations of glucose for 24-h (upper panel). MDA-MB-231 and MDA-MB-468 cells were 
cultured in glucose-depleted medium for different time periods as indicated (2nd and 3rd panels). 
Non-contiguous lanes were separated by a dashed line. (C, D) Induction of pS473-KAP1 by 
diverse metabolic stresses in MDA-MB-231 and MCF7 cells. (C) MDA-MB-231 (right panel) and 
MCF7 (left panel) cells were starved of glucose or glutamine or treated with 2-DG as indicated. 
(D) Arginine depletion or Etomoxir induces time-dependent KAP1 Ser473-phosphorylation in 
MDA-MB-231 cells. MDA-MB-231 cells were subjected to arginine depletion (upper panel). MDA-
MB-231 and MCF7 cells were treated with increasing concentrations of Etomoxir (lower panel). 
(E) Blocking p38 signaling blunts glucose and glutamine depletion-induced pS473-KAP1. 
SB203580 reduced glucose or glutamine depletion-induced pS473-KAP1 (upper panel). p38α 
knockdown dampened pS473-KAP1 induction in response to glucose depletion (lower panel). p-
p38: T180/Y182-phosphorylated p38MAPK.  
Figure 2. KAP1 Ser473 phosphorylation reduces the level of glucose deprivation-
promoted mitochondrial fusion. (A) Knockdown of KAP1 or repletion with S473D-KAP1 
reduces basal and maximal mitochondrial respiration. OCR was measured (upper panel) in 
different KAP1-expressing cells (lower panel). Mean±SD from n=3. (B) Glucose depletion 
promotes mitochondrial fusion. MDA-MB-231 cells were pre-treated with vehicle or Mdivi-1 (20 
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µM) for 18-h prior to glucose starvation. Arrowhead: tubulated mitochondria; scale bar: 10 µm; 
n>3. (C) Expression of S473A-KAP1 favors mitochondrial fusion in glucose-starved MDA-MB-
231/shKAP1 cells. Representative images of the typical fragmented, intermediate and tubulated 
mitochondrial network are shown (left panel). Quantitation (%) of cells with each mitochondrial 
morphology (right panel; n=80; also see Supplementary Figure S5A). (D) Mdivi-1 treatment 
mirrors glucose starvation to induce basal and maximal mitochondrial respiration. MDA-MB-231 
cells were pre-treated with vehicle or Mdivi-1 (20 µM) for 18-h prior to glucose starvation (6-h); 
n=3. (E) Mdivi-1 further induces the ROS level after glucose depletion. MDA-MB-231 cells were 
treated as in (D); n=3. (F) Repletion of S473A-KAP1 sensitizes MDA-MB-231/shKAP1 cells to 
glucose depletion. Cells were incubated with the decreasing concentrations of glucose for 72-h. 
Mean±SD from n=3; *: p<0.05, ***: p<0.001. 
Figure 3. KAP1 Ser473 phosphorylation reduces OCR via MFN2 down-regulation and 
regulates mitochondrial gene expression. (A) Glucose depletion down-regulates MFN2 
protein abundance. (B) Arginine depletion down-regulates MFN2 in MDA-MB-231 cells. (C) 
KAP1 S473A substitution retards MFN2 down-regulation in glucose-starved MDA-MB-
231/shKAP1 cells. Relative MFN2 abundance is calculated by designating the level in control 
MDA-MB-231 cells (A, B) or MDA-MB-231/shKAP1 cells (C) as 1 after normalization with 
GAPDH and shown in italic. (D) Knockdown of MFN2 reduces basal OCR in different KAP1-
expressing cells. MFN2 was knocked down by siRNA in different KAP1-expressing cells. SA: 
S473A-KAP1, SD: S473D-KAP1. (E) The ROS level is higher in S473A-KAP1 re-expressing 
MDA-MB-231/shKAP1 cells. Cells were cultured in complete (Ctrl) or glucose depletion medium 
(Glc-) for 6-h. Relative oxidized DCF levels were calculated by designating the value in wt-KAP1 
re-expressing MDA-MB-231/shKAP1 as 1. (F) ROS level is reduced in mfn2-/- MEFs. Relative 
oxidized DCF levels were calculated by designating the value in wt MEFs as 1. (G) Knockdown 
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and overexpression of MFN2 have opposite effect on cell viability under different nutrient 
starvation. Clonogenic survival fraction was calculated by designating cells in complete medium 
as 1. (D - G) Mean±SD from n=3; *: p<0.05, **: p<0.01, ***: p<0.01.  (H) S473D-KAP1 elevates 
expression of the mitochondrial complex genes. Relative message abundance was calculated by 
designating the respective message abundance in wt-KAP1-expressing MDA-MB-231/shKAP1 
cells as 1.  
Figure 4. MFN2 down-regulation is associated with mitochondrial fission in the core 
region of tumor. (A) A gradient decrease of MFN2 staining inwards to the core region of MDA-
MB-231/COX4-DsRed xenografts by IHC. Dotted lines depict borders of different regions as 
shown in the diagram (inset). Scale bar: 100 µm; n=2. (B) MFN2 is down-regulated in the core 
region of xenografted tumors. P: Peripheral region; C: Core; n=2. (C) Mitochondria are more 
fragmented in the core region of tumors. Mitochondrial morphologies are visualized with COX4-
DsRed in xenografted MDA-MB-231 cells (upper panel) and K-RASG12V-driven mouse salivary 
duct carcinoma (lower panel). Insets: enlarged views (upper panel); scale bar: 100 µm (upper 
panel) and 10 µm (lower panel). (D) Repletion of S473A-KAP1 reduces colony formation in MDA-
MB-231/shKAP1 cells. n=3 *: p<0.05; ***: p<0.005.  
Figure 5. Association of MFN2 with clinical prognosis. (A - G) Lower MFN2 is associated 
with adverse clinical features. (A) Reduced MFN2 expression is correlated with malignant breast 
tumors. Inversed MFN2 expression in low (panel a) and high (panel b) stage breast carcinoma 
and paired primary breast carcinoma (panel c) and its nodal deposition (panel d). (B) Reduced 
MFN2 expression is correlated with poor disease-specific and metastasis-free survival. (A, B) 
202 primary breast cancer samples from Chi-Mei Medical Center were used (also see Table 1). 
(C) MFN2 transcript level is down-regulated in primary and metastatic breast tumors compared 
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with normal tissues. The TCGA dataset was used. **: p<0.01; ***: p<0.005. (D - G) PrognoScan 
database-based Kaplan-Meier analysis in breast cancer datasets. The data are retrieved from 
the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) with the accession numbers 
GSE9893 (D), GSE11121 (E), GSE1379 (F) and GSE2990 (G), respectively. 
Figure 6. A KAP1/MFN2-dependent arm prevents mitochondrial hyperfusion during the 
course of metabolic stress. To maximize the utilization of available nutrients, mitochondria 
undergo fusion, which would generate excessive ROS in tumor cells distant from blood vessel. 
The elevated oxidative stress subsequently results in p38MAPK mediated pS473-KAP1 induction. 
pS473-KAP1 then suppresses mitochondrial hyperfusion via MFN2 down-regulation. 
 






